Gerald S Lipshutz MD
Kidney Transplantation
Associate Professor, Surgery, UCLA School of Medicine
Join to View Full Profile
757 Westwood Plaza, Suite 8501GLos Angeles, CA 90095
Phone+1 310-267-9592
Fax+1 310-267-9592
Dr. Lipshutz is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Residency, Surgery, 1993 - 2002
David Geffen School of Medicine at UCLAClass of 1993
Certifications & Licensure
CA State Medical License 1995 - 2027
American Board of Surgery Surgery
Awards, Honors, & Recognition
- Fellow (FACS) American College of Surgeons
Clinical Trials
- Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- Use of an oversized AAV8 vector for CPS1 deficiency results in long-term survival and ammonia control.Taryn Diep, Wesley Zhou, Rachel E Reyes, Matthew Nitzahn, Isabel L Day
Molecular Therapy. Nucleic Acids. 2025-03-11 - [F]FDG-PET and [F]MPPF-PET are brain biomarkers for the creatine transporter Slc6a8 loss of function mutation.Isabel Day, Mikayla Tamboline, Lindsay Lueptow, Irina Zhuravka, Taryn Diep
Scientific Reports. 2025-03-01 - Recent developments in translational imaging of in vivo gene therapy outcomes.Isabel L Day, Mikayla Tamboline, Gerald S Lipshutz, Shili Xu
Molecular Therapy. 2024-12-30
Press Mentions
UCLA Scientists Receive $17.4 Million in CIRM Grants to Advance Novel Stem-Cell Based TreatmentsMay 30th, 2024
Two Therapies Cure Rare Genetic Disease in MiceSeptember 10th, 2019
Grant Support
- Gene Therapy Clinical Candidate Development for Carbamoyl Phosphate Synthetase DeficiencyUNIVERSITY OF CALIFORNIA LOS ANGELES2022–2025
- Understanding the Mechanism and Preventing the Unique Neuropathology of Arginase DeficiencyUNIVERSITY OF CALIFORNIA LOS ANGELES2019–2024
- Pathophysiology And Gene Replacement Strategies For Arginase DeficiencyNational Institute Of Neurological Disorders And Stroke2010–2011
- The Immune Response To Viral Vector And Transgenes In The FetusEunice Kennedy Shriver National Institute Of Child Health &Human Development2007–2011
Professional Memberships
- Member
- Member
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
